Caris Life Sciences’ scientific experts and external collaborators are contributing to major advances in the understanding of blood-based circulating microvesicles (cMV) and their potential utility to aid in the diagnosis, prognosis, and theranosis of cancer and other complex diseases. Posters and abstracts highlighting the promise of ADAPT Biotargeting Systemâ„¢ are listed below.

Spectrum of BAP1 mutations identified in diverse cancer lineages

A novel liquid biopsy method method for detection of breast cancer

The B-cell Lymphoma Specific Aptamer C10.36 Binds a Ribonucleoprotein Complex on the Cell Surface of Cancer Cells

Small non-coding RNA profiling from prostate cancer plasma by deep sequencing

Adaptive dynamic artificial polyligand targeting (ADAPT): A Method to identify exosomal proteins from a prostate cancer cell line

A comparative analysis of PD-L1 distribution in primary NSCLC and metastatic tumors to the lung

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Molecular Variances Between Rectal and Left-Sided Colon Cancers (Presentation)

Molecular Variances Between Rectal and Left Sided Colon Cancers

Molecular characterization of squamous cell carcinoma of the anal canal (SCCA)